{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:52:38Z","timestamp":1793962358969,"version":"4.8.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.yjmcc.2010.10.020","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T08:24:39Z","timestamp":1288340679000},"page":"479-484","source":"Crossref","is-referenced-by-count":61,"title":["\u03b2IIPKC and \u03b5PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure"],"prefix":"10.1016","volume":"51","author":[{"given":"Julio Cesar Batista","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Chakur","family":"Brum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Mochly-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2010.10.020_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pcad.2009.05.002","article-title":"Clinical impact of left ventricular hypertrophy and implications for regression","volume":"52","author":"Artham","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0002-9343(84)90430-3","article-title":"Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy","volume":"77","author":"Messerli","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy","volume":"115","author":"Dorn","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0025","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1016\/S0021-9258(17)41010-6","article-title":"Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain","volume":"252","author":"Inoue","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0030","doi-asserted-by":"crossref","first-page":"L429","DOI":"10.1152\/ajplung.2000.279.3.L429","article-title":"Protein kinase C isozymes and the regulation of diverse cell responses","volume":"279","author":"Dempsey","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1096\/fasebj.12.1.35","article-title":"Anchoring proteins for protein kinase C: a means for isozyme selectivity","volume":"12","author":"Mochly-Rosen","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0040","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1021\/bi802171c","article-title":"Regulatory autophosphorylation sites on protein kinase C-delta at threonine-141 and threonine-295","volume":"48","author":"Rybin","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0700877","article-title":"Protein kinase C isoenzymes in rat and human cardiovascular tissues","volume":"120","author":"Erdbrugger","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0050","doi-asserted-by":"crossref","first-page":"C1350","DOI":"10.1152\/ajpcell.1993.264.5.C1350","article-title":"Use of a PCR-based method to characterize protein kinase C isoform expression in cardiac cells","volume":"264","author":"Kohout","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0055","doi-asserted-by":"crossref","first-page":"H2062","DOI":"10.1152\/ajpheart.2001.281.5.H2062","article-title":"Protein kinase C isoform expression and activity in the mouse heart","volume":"281","author":"Schreiber","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.99.3.384","article-title":"Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart","volume":"99","author":"Bowling","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0008-6363(00)00185-1","article-title":"Molecular heterogeneity of protein kinase C expression in human ventricle","volume":"48","author":"Shin","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11010-007-9533-3","article-title":"Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy","volume":"305","author":"Simonis","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/01.RES.79.2.153","article-title":"Protein kinase C isoform expression in normal and failing rabbit hearts","volume":"79","author":"Rouet-Benzineb","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0080","doi-asserted-by":"crossref","first-page":"H2500","DOI":"10.1152\/ajpheart.2001.281.6.H2500","article-title":"Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1","volume":"281","author":"Pass","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00424-007-0420-2","article-title":"Maladaptation of calcium homoeostasis in aging cardiac myocytes","volume":"456","author":"Goldspink","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0090","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1006\/jmcc.2002.2089","article-title":"Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta","volume":"34","author":"Inagaki","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0828-282X(06)70315-4","article-title":"Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies","volume":"22","author":"Machackova","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.pharmtox.48.121806.154902","article-title":"PKC isozymes in chronic cardiac disease: possible therapeutic targets?","volume":"48","author":"Churchill","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvp001","article-title":"Protein kinase C in heart failure: a therapeutic target?","volume":"82","author":"Palaniyandi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0115","doi-asserted-by":"crossref","first-page":"29644","DOI":"10.1074\/jbc.M101044200","article-title":"Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C","volume":"276","author":"Stebbins","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.RES.72.4.757","article-title":"Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin","volume":"72","author":"Bogoyevitch","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0125","doi-asserted-by":"crossref","first-page":"H946","DOI":"10.1152\/ajpheart.2001.280.3.H946","article-title":"PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression","volume":"280","author":"Pass","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0130","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.RES.86.12.1218","article-title":"Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy","volume":"86","author":"Takeishi","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.200108062","article-title":"PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1\/2 (ERK1\/2)","volume":"156","author":"Braz","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm1000","article-title":"PKC-alpha regulates cardiac contractility and propensity toward heart failure","volume":"10","author":"Braz","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0145","doi-asserted-by":"crossref","first-page":"11114","DOI":"10.1073\/pnas.191369098","article-title":"Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC","volume":"98","author":"Chen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0150","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.82.11.1173","article-title":"Increased protein kinase C activity in myotrophin-induced myocyte growth","volume":"82","author":"Sil","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0155","doi-asserted-by":"crossref","first-page":"12798","DOI":"10.1073\/pnas.96.22.12798","article-title":"Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation","volume":"96","author":"Dorn","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.86.11.1173","article-title":"Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation","volume":"86","author":"Mochly-Rosen","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0165","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/HYPERTENSIONAHA.107.109637","article-title":"Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure","volume":"51","author":"Inagaki","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.yjmcc.2008.08.009","article-title":"Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure","volume":"45","author":"Palaniyandi","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0175","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1073\/pnas.94.17.9320","article-title":"Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy","volume":"94","author":"Wakasaki","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0180","first-page":"S535","article-title":"Pharmacological \u03b2IIPKC inhibition is cardioprotective in late-stage hypertrophy and end-stage heart failure in two rat models","volume":"118","author":"Ferreira","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0185","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.yjmcc.2007.09.015","article-title":"Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells","volume":"43","author":"Moschella","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0190","doi-asserted-by":"crossref","first-page":"32848","DOI":"10.1016\/S0021-9258(20)30069-7","article-title":"Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts","volume":"269","author":"Clerk","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11010-009-0061-1","article-title":"Regulation of c-Fos and c-Jun gene expression by phospholipase C activity in adult cardiomyocytes","volume":"327","author":"Singal","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0200","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/hh2201.099434","article-title":"Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes","volume":"89","author":"Heidkamp","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0205","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1128\/MCB.25.22.9829-9844.2005","article-title":"Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.yjmcc.2005.06.016","article-title":"TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation","volume":"39","author":"Lim","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0215","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","article-title":"Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5","volume":"24","author":"Vega","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1172\/JCI2709","article-title":"In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts","volume":"102","author":"Takeishi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0225","series-title":"ISHR North American Section Meeting","article-title":"Protein quality control disruption by PKC\u03b2II in heart failure","author":"Ferreira","year":"2009"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2005.03.008","article-title":"Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction","volume":"39","author":"Boyle","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0969-2126(04)00007-3","article-title":"Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1","volume":"12","author":"Komander","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0240","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/0008-5472.CAN-05-0071","article-title":"The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts","volume":"65","author":"Graff","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0245","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nbt1098-919","article-title":"Peptide modulators of protein\u2013protein interactions in intracellular signaling","volume":"16","author":"Souroujon","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0250","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1126\/science.1158554","article-title":"Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart","volume":"321","author":"Chen","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvp334","article-title":"Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion","volume":"85","author":"Churchill","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0260","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1158\/0008-5472.CAN-07-6195","article-title":"Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0265","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.yjmcc.2007.06.003","article-title":"Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model","volume":"43","author":"Koyanagi","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0270","first-page":"173","article-title":"Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood\u2013brain barrier breakdown in rats","volume":"118","author":"Qi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0275","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cncr.11909","article-title":"A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma","volume":"100","author":"Advani","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0285","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ophtha.2006.07.032","article-title":"Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy","volume":"113","author":"Aiello","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0290","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.107.759167","article-title":"Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction","volume":"117","author":"Bates","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1215\/S1152851703000353","article-title":"Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas","volume":"7","author":"Grossman","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0300","doi-asserted-by":"crossref","unstructured":"Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol. 2007; 125: 318-24.","DOI":"10.1001\/archopht.125.3.318"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0305","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2008.03.004","article-title":"Ultrasonic gene and drug delivery to the cardiovascular system","volume":"60","author":"Mayer","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0310","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1006\/jmcc.2001.1442","article-title":"Protein kinase C(epsilon) modulates apoptosis induced by beta -adrenergic stimulation in adult rat ventricular myocytes via extracellular signal-regulated kinase (ERK) activity","volume":"33","author":"Shizukuda","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0315","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.RES.0000161999.86198.1e","article-title":"Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon","volume":"96","author":"Klein","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0320","first-page":"H53","article-title":"Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure","volume":"276","author":"Takeishi","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0325","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1291\/hypres.26.421","article-title":"Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats","volume":"26","author":"Koide","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0330","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1172\/JCI119755","article-title":"Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates","volume":"100","author":"Bowman","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0335","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.RES.85.3.264","article-title":"Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated","volume":"85","author":"Takeishi","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0340","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1074\/jbc.275.18.13571","article-title":"Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways","volume":"275","author":"De Windt","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.10.020_bb0345","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1073\/pnas.89.22.11059","article-title":"Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation","volume":"89","author":"Inoguchi","year":"1992","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282810003998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282810003998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T21:04:25Z","timestamp":1636751065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282810003998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0022282810003998"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2010.10.020","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}